Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
2 Healthcare Stocks with Competitive Advantages and 1 We Question
09.09.2026 14:34
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 25.7% over the past six months while the S&P 500 was up 13.6%.
Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
09.09.2026 09:04
Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.
How Much Upside Can BSX Stock's Growth Deliver?
04.09.2026 18:25
While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are performing consistently with their historical track record, though this durable base's near-term ~6% growth leaves our 10.8% three-year CAGR reliant on a post-2026 pipeline re-acceleration.
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
04.09.2026 15:12
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
Boston Scientific begins to restore shipping after cyberattack
04.09.2026 11:30
The company is working through a backlog after the cyberattack hampered manufacturing, order processing and shipping.
Did Recalls And Cyberattack Disruptions Just Shift Boston Scientific's (BSX) Investment Narrative?
04.09.2026 09:21
In recent weeks, Boston Scientific has faced multiple voluntary global recalls of its Suture Cinch endoscopic devices and ENROUTE Transcarotid Neuroprotection systems, alongside a cybersecurity incident that disrupted operations and led to reduced full‑year 2026 sales and earnings guidance. These simultaneous product quality issues, operational disruptions, and softer demand for key franchises raise fresh questions about the resilience of Boston Scientific’s previously growth-focused...
Boston Scientific (NYSE:BSX) Stands Out as a Quality Investment
27.08.2026 11:51
Boston Scientific passes the Caviar Cruise quality screen with strong ROIC, cash conversion, and attractive valuation.
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals
12.08.2026 11:52
Boston Scientific (BSX) screens as a decent value: cheap vs peers, strong profitability, and solid health, scoring 7/10.
Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players
11.08.2026 09:05
Pulsed Field Ablation Market Pulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast till 2035" has been added to ResearchAndMarkets.com's offering. The global pulsed field ablation market is projected to expand from approximately USD 3.2 billion in 2026 to USD 14.6 billion by 2035, re
Artisan Global Equity Fund Q2 2026 Portfolio Review
11.08.2026 05:10
The portfolio underperformed the MSCI All Country World Index during Q2. Read more here.
Artisan Global Equity Fund Q2 2026 Portfolio Review
11.08.2026 05:10
The portfolio underperformed the MSCI All Country World Index during Q2. Read more here.
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone
11.08.2026 01:20
Despite U.S. growth headwinds for WATCHMAN and electrophysiology, Boston Scientific delivered strong Q2 2026 results. Read why BSX stock is a Strong Buy.
Boston Scientific Director Habiger Buys $100k of Shares Amid 54% Decline. What Does This Mean for BSX in 2026?
10.08.2026 18:14
Habiger's $100,000 purchase expanded his direct holdings by 14%, signaling confidence despite the stock's recent weakness. The acquisition came as shares traded near their lowest levels in over a year.
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?
10.08.2026 17:46
Mahoney expanded his equity stake by 13% following a -54% one-year stock decline. His combined holdings now total ~1.6 million shares valued at $78.08 million.
Boston Scientific (BSX) Q2 2026 Earnings Call Transcript
08.08.2026 00:14
WATCHMAN and Electrophysiology headwinds force guidance cut despite solid organic growth.
2 Profitable Stocks to Keep an Eye On and 1 We Turn Down
04.08.2026 12:13
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure
30.07.2026 14:00
BSX faces WATCHMAN and EP pressures as management cuts outlook while highlighting cost savings and new product catalysts for future growth.
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $57
30.07.2026 11:08
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $62 to $57.